documents: 2023-20902
title | type | abstract | document_number | html_url | pdf_url | public_inspection_pdf_url | publication_date | agencies | excerpts |
---|---|---|---|---|---|---|---|---|---|
Discussion Paper: Artificial Intelligence in Drug Manufacturing, Notice; Request for Information and Comments; Reopening of the Comment Period | Notice | The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice, published in the Federal Register of March 1, 2023, establishing a public docket and requesting information and comments. FDA is reopening the comment period to update comments and to receive any new information. | 2023-20902 | https://www.federalregister.gov/documents/2023/09/27/2023-20902/discussion-paper-artificial-intelligence-in-drug-manufacturing-notice-request-for-information-and | https://www.govinfo.gov/content/pkg/FR-2023-09-27/pdf/2023-20902.pdf | https://public-inspection.federalregister.gov/2023-20902.pdf?1695732323 | 2023-09-27 | [ "Health and Human Services Department", "Food and Drug Administration" ] |
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice, published in the Federal Register of March 1, 2023, establishing a public docket and requesting information and comments. FDA is reopening the comment... |